Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized studyShi, Y K ; Wang, L ; Han, B H ; Li, W ; Yu, P ; Liu, Y P ; Ding, C M ; Song, X ; Ma, Z Y ; Ren, X L ; Feng, J F ; Zhang, H L ; Chen, G Y ; Han, X H ; Wu, N ; Yao, C ; Song, Y ; Zhang, S C ; Song, W ; Liu, X Q ; Zhao, S J ; Lin, Y C ; Ye, X Q ; Li, K ; Shu, Y Q ; Ding, L M ; Tan, F L ; Sun, YAnnals of oncology, 2017-10, Vol.28 (10), p.2443 [Periódico revisado por pares]EnglandTexto completo disponível |
|
2 |
Material Type: Artigo
|
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung CancerMok, Tony S ; Wu, Yi-Long ; Ahn, Myung-Ju ; Garassino, Marina C ; Kim, Hye R ; Ramalingam, Suresh S ; Shepherd, Frances A ; He, Yong ; Akamatsu, Hiroaki ; Theelen, Willemijn S.M.E ; Lee, Chee K ; Sebastian, Martin ; Templeton, Alison ; Mann, Helen ; Marotti, Marcelo ; Ghiorghiu, Serban ; Papadimitrakopoulou, Vassiliki AThe New England journal of medicine, 2017-02, Vol.376 (7), p.629-640 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
3 |
Material Type: Artigo
|
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)Yang, Yunpeng ; Wang, Zhehai ; Fang, Jian ; Yu, Qitao ; Han, Baohui ; Cang, Shundong ; Chen, Gongyan ; Mei, Xiaodong ; Yang, Zhixiong ; Ma, Rui ; Bi, Minghong ; Ren, Xiubao ; Zhou, Jianying ; Li, Baolan ; Song, Yong ; Feng, Jifeng ; Li, Juan ; He, Zhiyong ; Zhou, Rui ; Li, Weimin ; Lu, You ; Wang, Yingyi ; Wang, Lijun ; Yang, Nong ; Zhang, Yan ; Yu, Zhuang ; Zhao, Yanqiu ; Xie, Conghua ; Cheng, Ying ; Zhou, Hui ; Wang, Shuyan ; Zhu, Donglei ; Zhang, Wen ; Zhang, LiJournal of thoracic oncology, 2020-10, Vol.15 (10), p.1636-1646 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
Diselenide–Pemetrexed Assemblies for Combined Cancer Immuno‐, Radio‐, and ChemotherapiesLi, Tianyu ; Pan, Shuojiong ; Gao, Shiqian ; Xiang, Wentian ; Sun, Chenxing ; Cao, Wei ; Xu, HuapingAngewandte Chemie International Edition, 2020-02, Vol.59 (7), p.2700-2704 [Periódico revisado por pares]Germany: Wiley Subscription Services, IncTexto completo disponível |
|
5 |
Material Type: Artigo
|
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung CancerBorghaei, Hossein ; Langer, Corey J. ; Gadgeel, Shirish ; Papadimitrakopoulou, Vassiliki A. ; Patnaik, Amita ; Powell, Steven F. ; Gentzler, Ryan D. ; Martins, Renato G. ; Stevenson, James P. ; Jalal, Shadia I. ; Panwalkar, Amit ; Yang, James Chih-Hsin ; Gubens, Matthew ; Sequist, Lecia V. ; Awad, Mark M. ; Fiore, Joseph ; Saraf, Sanatan ; Keller, Steven M. ; Gandhi, LeenaJournal of thoracic oncology, 2019-01, Vol.14 (1), p.124-129 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
A firm asymptomatic erythematous nodule on the templeEstenaga, Angela ; Vallejo, RafaelIndian journal of dermatology, 2021-09, Vol.66 (5), p.577 [Periódico revisado por pares]Medknow Publications and Media Pvt. LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung CancerGadgeel, Shirish ; Rodríguez-Abreu, Delvys ; Speranza, Giovanna ; Esteban, Emilio ; Felip, Enriqueta ; Dómine, Manuel ; Hui, Rina ; Hochmair, Maximilian J ; Clingan, Philip ; Powell, Steven F ; Cheng, Susanna Yee-Shan ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Garon, Edward B ; Novello, Silvia ; Rubio-Viqueira, Belén ; Boyer, Michael ; Kurata, Takayasu ; Gray, Jhanelle E ; Yang, Jing ; Bas, Tuba ; Pietanza, M Catherine ; Garassino, Marina CJournal of clinical oncology, 2020-05, Vol.38 (14), p.1505-1517 [Periódico revisado por pares]United StatesTexto completo disponível |
|
8 |
Material Type: Artigo
|
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 InsertionsZhou, Caicun ; Tang, Ke-Jing ; Cho, Byoung Chul ; Liu, Baogang ; Paz-Ares, Luis ; Cheng, Susanna ; Kitazono, Satoru ; Thiagarajan, Muthukkumaran ; Goldman, Jonathan W ; Sabari, Joshua K ; Sanborn, Rachel E ; Mansfield, Aaron S ; Hung, Jen-Yu ; Boyer, Michael ; Popat, Sanjay ; Mourão Dias, Josiane ; Felip, Enriqueta ; Majem, Margarita ; Gumus, Mahmut ; Kim, Sang-We ; Ono, Akira ; Xie, John ; Bhattacharya, Archan ; Agrawal, Trishala ; Shreeve, S Martin ; Knoblauch, Roland E ; Park, Keunchil ; Girard, NicolasThe New England journal of medicine, 2023-11, Vol.389 (22), p.2039-2051 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
9 |
Material Type: Artigo
|
Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivativePangeni, Rudra ; Jha, Saurav Kumar ; Maharjan, Ruby ; Choi, Jeong Uk ; Chang, Kwan-Young ; Choi, Young Kweon ; Byun, Youngro ; Park, Jin WooInternational journal of nanomedicine, 2019-01, Vol.14, p.6339-6356 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
10 |
Material Type: Artigo
|
Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancersDrilon, A. ; Bergagnini, I. ; Delasos, L. ; Sabari, J. ; Woo, K.M. ; Plodkowski, A. ; Wang, L. ; Hellmann, M.D. ; Joubert, P. ; Sima, C.S. ; Smith, R. ; Somwar, R. ; Rekhtman, N. ; Ladanyi, M. ; Riely, G.J. ; Kris, M.G.Annals of oncology, 2016-07, Vol.27 (7), p.1286-1291 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |